Újabb klinikai adatok a daganatos betegek anémiá jának erythropoetinkezelésében

Research output: Contribution to journalArticle

1 Citation (Scopus)


Anemia of patients with malignancy might have various reasons. No matter if its background is the underlying tumorous disease or chemo- and/or radiotherapy, it can cause fatigue, malaise, it certainly decreases the patients' quality of life and, furthermore, shortens their survival. Chronic hypoxia caused by anemia promotes tumor progression by several mechanisms e.g. by enhancing angioneogenesis by the production of VEGF. At the same time it decreases the efficacy of chemo- and radiotherapy. Therefore, prevention and/or correction of chemo/radiotherapy-induced anemia is a major goal of modern oncotherapy.

Original languageHungarian
Pages (from-to)251-254
Number of pages4
JournalMagyar onkologia
Issue number3
Publication statusPublished - Jan 1 2005

ASJC Scopus subject areas

  • Medicine(all)

Cite this